Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Drug or technology

HJB647 low dose

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 10, 2026 · PHASE 1 TRIAL

A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction

ClinicalTrials.gov

Phase 1 safety and tolerability study with planned enrollment of 12 participants; no results posted in this registry record.

PreliminaryHJB647 low dose Heart Failure With Reduced Ejection Fraction HJB647 high dose

Reported

Planned enrollment12

PhasePhase 1

Primary outcome measure 1Number of participants with Adverse Events…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support